Model for end-stage liver disease-sodium in acute-on-chronic liver failure
- PMID: 32933782
- DOI: 10.1016/j.jhep.2020.07.022
Model for end-stage liver disease-sodium in acute-on-chronic liver failure
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Model for end-stage liver disease-sodium in acute-on-chronic liver failure".J Hepatol. 2020 Dec;73(6):1579-1580. doi: 10.1016/j.jhep.2020.08.004. Epub 2020 Sep 25. J Hepatol. 2020. PMID: 32988657 No abstract available.
Comment on
-
Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.J Hepatol. 2020 Dec;73(6):1425-1433. doi: 10.1016/j.jhep.2020.06.005. Epub 2020 Jun 10. J Hepatol. 2020. PMID: 32531416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
